BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11517741)

  • 1. [Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue].
    Stanislav ML; Balabanova RM; Alekperov RT; Miagkova MA; Abramenko TV; Kiselev IP; Kost OA; Nikol'skaia II; Garats EV
    Ter Arkh; 2001; 73(5):20-5. PubMed ID: 11517741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates].
    Kostrikin DS; Panchenko ON; Miagkova MA; Stanislav ML; Kost OA; Nikol'skaia II; Pogozheva AV; Kiselev IP; Valuev DI
    Klin Med (Mosk); 2003; 81(9):31-4. PubMed ID: 14598588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
    Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
    Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineutrophil cytoplasmic antibodies in patients with diffuse diseases of connective tissue].
    Dadonene I; Redaĭtene E; Shaulauskene I; Kirdaĭte G; Vasiliauskene L
    Ter Arkh; 2002; 74(5):38-43. PubMed ID: 12087904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA-abzymes and their clinical significance in systemic lupus erythematosis].
    Suchkov SV; Gabibov AG; Alekberova ZS; Gnuchev NV
    Ter Arkh; 2001; 73(10):58-65. PubMed ID: 11763520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics)].
    Riazantseva TA; Shakhanina KL; Aroian AA; Speranskiĭ AI
    Ter Arkh; 1987; 59(8):86-91. PubMed ID: 3317973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
    Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases.
    Takahashi Y; Haga S; Ishizaka Y; Mimori A
    Arthritis Res Ther; 2010; 12(3):R85. PubMed ID: 20470389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.